Axsome Therapeutics, Inc.
DE ˙ DB ˙ US05464T1043
199,30 € ↑9,50 (5,01%)
2026-06-04
AKTIENPREIS
SecurityDE:19X / Axsome Therapeutics, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership5,920 shares
Latest Disclosed Value $ 1,000,563
Stifel Financial Corp reports 0.89% increase in ownership of 19X / Axsome Therapeutics, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 5,920 shares of Axsome Therapeutics, Inc. (DE:19X) valued at $830,576 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,868 shares of Axsome Therapeutics, Inc.. This represents a change in shares of 0.89% during the quarter. The current value of the position is $1,179,856 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AXSOME THERAPEUTICS COM 05464T104 5,920 52 0.89 1,001 -6.63 0.0002
2026-02-13 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 5,868 361 6.56 1,072 60.33 0.0010
2025-11-12 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 5,507 1,185 27.42 669 48.12 0.0006
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 4,322 4,322 451 0.0004
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 0 -406,935 -100.00 0 -100.00
2021-08-13 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 406,935 136 0.03 27,452 19.19 0.0411
2021-05-14 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 406,799 769 0.19 23,033 -30.37 0.0380
2021-02-12 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 406,030 -538 -0.13 33,079 14.19 0.0590
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 406,568 -30 -0.01 28,968 -13.41 0.0596
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 406,598 2,453 0.61 33,454 40.70 0.0769
2020-05-14 2020-03-31 13F AXSOME THERAPEUTICS COM 05464T104 404,145 0 0.00 23,776 -43.08 0.0657
2020-02-13 2019-12-31 13F AXSOME THERAPEUTICS COM 05464T104 404,145 0 0.00 41,772 410.66 0.0870
2019-11-19 2019-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 404,145 -374 -0.09 8,180 -21.47 0.0209
2019-11-13 2019-09-30 13F AXSOME THERAPEUTICS COM 05464T104 404,145 -374 8,180 4,585.3000
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS COM 05464T104 404,519 374 0.09 10,417 81.13 0.0269
2019-05-14 2019-03-31 13F AXSOME THERAPEUTICS COM 05464T104 404,145 0 0.00 5,751 404.47 0.0163
2019-02-13 2018-12-31 13F AXSOME THERAPEUTICS COM 05464T104 404,145 0 0.00 1,140 -18.22 0.0037
2018-11-13 2018-09-30 13F AXSOME THERAPEUTICS COM 05464T104 404,145 0 0.00 1,394 7.81 0.0040
2018-08-14 2018-06-30 13F AXSOME THERAPEUTICS COM 05464T104 404,145 0 0.00 1,293 30.61 0.0040
2018-05-11 2018-03-31 13F AXSOME THERAPEUTICS COM 05464T104 404,145 -11,134 -2.68 990 -57.44 0.0031
2018-02-14 2017-12-31 13F AXSOME THERAPEUTICS COM 05464T104 415,279 0 0.00 2,326 0.91 0.0074
2017-11-13 2017-09-30 13F AXSOME THERAPEUTICS COM 05464T104 415,279 0 0.00 2,305 0.92 0.0080
2017-08-14 2017-06-30 13F AXSOME THERAPEUTICS COM 05464T104 415,279 0 0.00 2,284 40.99 0.0085
2017-05-10 2017-03-31 13F AXSOME THERAPEUTICS COM 05464T104 415,279 0 0.00 1,620 -42.20 0.0063
2017-02-16 2016-12-31 13F AXSOME THERAPEUTICS COM 05464T104 415,279 0 0.00 2,803 -14.33 0.0119
2016-11-15 2016-09-30 13F AXSOME THERAPEUTICS COM 05464T104 415,279 415,279 3,272 0.0147
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.